Announcements Trials
Browse Landscape

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Breast Neoplasms 6Neoplasms 3Lung Neoplasms 3Uterine Cervical Neoplasms 2Smoking Cessation 2Prostatic Neoplasms 2Communication 2Colorectal Neoplasms 2Uveal Melanoma 1Triple Negative Breast Neoplasms 1Tobacco Use Cessation 1Thyroid Neoplasms 1Sexual Dysfunction, Physiological 1Rectal Neoplasms 1Patient Preference 1Patient Acceptance of Health Care 1Papillary Thyroid Microcarcinoma 1Melanoma 1Lung Cancer Screening 1Hematologic Neoplasms 1Health Behavior 1Glioblastoma 1Gastrointestinal Neoplasms 1Endometrial Neoplasms 1Cancer Prevention 1Cancer Pain 1Brain Neoplasms 1Attitude to Health 1

Interventions

Cyclophosphamide 32Tacrolimus 29fludarabine 27Mycophenolic Acid 23fludarabine phosphate 22Busulfan 19Whole-Body Irradiation 18Melphalan 16Methotrexate 15Antilymphocyte Serum 14Rituximab 12Bortezomib 11Stem Cell Transplantation 10Cyclosporine 10thymoglobulin 9Sirolimus 9Granulocyte Colony-Stimulating Factor 9Peripheral Blood Stem Cell Transplantation 8Thiotepa 7Interviews as Topic 7Filgrastim 7Dexamethasone 7Clofarabine 7Blood Specimen Collection 6Alemtuzumab 6merphos 5Voriconazole 5Standard of Care 5Nivolumab 5Lenalidomide 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Hematologic Neoplasms × Focus Groups × Clear all
NCT04694911 2025-04-29

Development of the Oncology Opportunity Cost Assessment Tool

Thomas Jefferson University

Completed
40 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡